Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Uitdehaag, BMJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 30 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hoogervorst, ELJ; Kalkers, NF; van Winsen, LML; Uitdehaag, BMJ; Polman, CH
      Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis

      MULTIPLE SCLEROSIS
    2. Killestein, J; Den Drijver, BF; Van der Graaff, WL; Uitdehaag, BMJ; Polman, CH; Van Lier, RAW
      Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease

      MULTIPLE SCLEROSIS
    3. Uitdehaag, BMJ; Hoekstra, K; Koper, JW; Polman, CH; Dijkstra, CD
      IFN-beta 1b augments glucocorticoid-induced suppression of tumor necrosis factor-alpha production by increasing the number of glucocorticoid receptors on a human monocytic cell line

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    4. Polman, CH; Uitdehaag, BMJ
      Drug treatment of multiple sclerosis - Clinical review was unsystematic - Reply

      BRITISH MEDICAL JOURNAL
    5. Head, MW; Tissingh, G; Uitdehaag, BMJ; Barkhof, F; Bunn, TJR; Ironside, JW; Kamphorst, W; Scheltens, P
      Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: Atypical molecular phenotype

      ANNALS OF NEUROLOGY
    6. van Veen, T; Crusius, JBA; Schrijver, HM; Bouma, G; Killestein, J; van Winsen, L; Pena, AS; Polman, CH; Uitdehaag, BMJ
      Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis

      ANNALS OF NEUROLOGY
    7. Hoogervorst, ELJ; van Winsen, LML; Eikelenboom, MJ; Kalkers, NF; Uitdehaag, BMJ; Polman, CH
      Comparisons of patient self-report, neurologic examination, and functionalimpairment in MS

      NEUROLOGY
    8. Kalkers, NF; Bergers, L; de Groot, V; Lazeron, RHC; van Walderveen, MAA; Uitdehaag, BMJ; Polman, CH; Barkhof, F
      Concurrent validity of the MS functional composite using MRI as a biological disease marker

      NEUROLOGY
    9. Gerritsen, AAM; Uitdehaag, BMJ; van Geldere, D; Scholten, RJPM; de Vet, HCW; Bouter, LM
      Systematic review of randomized clinical trials of surgical treatment for carpal tunnel syndrome

      BRITISH JOURNAL OF SURGERY
    10. Arnoldus, JHA; Killestein, J; Pfennings, LEMA; Jelles, B; Uitdehaag, BMJ; Polman, CH
      Quality of life during the first 6 months of interferon-beta treatment in patients with MS

      MULTIPLE SCLEROSIS
    11. Nijeholt, GJLA; Castelijns, JA; Lazeron, RHC; van Waesberghe, JHTM; Polman, CH; Uitdehaag, BMJ; Barkhof, F
      Magnetization transfer ratio of the spinal cord in multiple sclerosis: Relationship to atrophy and neurologic disability

      JOURNAL OF NEUROIMAGING
    12. Polman, CH; Uitdehaag, BMJ
      Regular review - Drug treatment of multiple sclerosis

      BRITISH MEDICAL JOURNAL
    13. Nijeholt, GJLA; Uitdehaag, BMJ; Bergers, E; Castelijns, JA; Polman, CH; Barkhof, F
      Spinal cord magnetic resonance imaging in suspected multiple sclerosis

      EUROPEAN RADIOLOGY
    14. de Jong, BA; Schrijver, HM; Huizinga, TWJ; Bollen, ELEM; Polman, CH; Uitdehaag, BMJ; Kersbergen, MC; Sturk, A; Westendorp, RGJ
      Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis

      ANNALS OF NEUROLOGY
    15. Killestein, J; Schrijver, HM; Crusius, JBA; Perez, C; Uitdehaag, BMJ; Pena, AS; Polman, CH
      Intracellular adhesion molecule-1 polymorphisms and genetic susceptibilityto multiple sclerosis: Additional data and meta-analysis

      ANNALS OF NEUROLOGY
    16. Polman, CH; Uitdehaag, BMJ
      Drug treatment of multiple sclerosis

      WESTERN JOURNAL OF MEDICINE
    17. Nasseri, K; Uitdehaag, BMJ; van Walderveen, MAA; Ader, HJ; Polman, CH
      Cardiovascular autonomic function in patients with relapsing remitting multiple sclerosis: a new surrogate marker of disease evolution?

      EUROPEAN JOURNAL OF NEUROLOGY
    18. Schrijver, HM; Crusius, JBA; Uitdehaag, BMJ; Gonzalez, MAG; Kostense, PJ; Polman, CH; Pena, AS
      Association of interleukin-1 beta and interleukin-1 receptor antagonist genes with disease severity in MS

      NEUROLOGY
    19. UITDEHAAG BMJ; BARKHOF F
      METHYLPREDNISOLONE FOR ACUTE RELAPSES OF MULTIPLE-SCLEROSIS - CAN ORAL REPLACE INTRAVENOUS ADMINISTRATION

      CNS drugs
    20. ROMBOUTS SARB; LAZERON RHC; SCHELTENS P; UITDEHAAG BMJ; SPRENGER M; VALK J; BARKHOF F
      VISUAL ACTIVATION PATTERNS IN PATIENTS WITH OPTIC NEURITIS - AN FMRI PILOT-STUDY

      Neurology
    21. NASSERI K; TENVOORDE BJ; ADER HJ; UITDEHAAG BMJ; POLMAN CH
      LONGITUDINAL FOLLOW-UP OF CARDIOVASCULAR REFLEX RESTS IN MULTIPLE-SCLEROSIS

      Journal of the neurological sciences
    22. KUNKELER ACM; UITDEHAAG BMJ; STOOF TJ
      FAMILIAL CAVERNOUS HEMANGIOMAS

      British journal of dermatology
    23. BARKHOF F; VANWAESBERGHE JHTM; UITDEHAAG BMJ; POLMAN CH
      IBUPROFEN DOES NOT SUPPRESS ACTIVE MULTIPLE-SCLEROSIS LESIONS ON GADOLINIUM-ENHANCED MR-IMAGES

      Annals of neurology
    24. VANWAESBERGHE JHTM; CASTELIJNS JA; ROSER W; SILVER N; YOUSRY T; NIJEHOLT GJLA; ADER HJ; UITDEHAAG BMJ; RADUE EW; POLMAN CH; KAPPOS L; MILLER DH; BARKHOF F
      SINGLE-DOSE GADOLINIUM WITH MAGNETIZATION-TRANSFER VERSUS TRIPLE-DOSEGADOLINIUM IN THE MR DETECTION OF MULTIPLE-SCLEROSIS LESIONS

      American journal of neuroradiology
    25. VANOOSTEN BW; UITDEHAAG BMJ; BARKHOF F; HARTUNG HP; WAGSTAFF J; POLMAN CH
      INTERLEUKIN-2 THERAPY DOES NOT EXACERBATE MULTIPLE-SCLEROSIS

      Neurology
    26. UITDEHAAG BMJ; POLMAN CH; SONTROP K; DIJKSTRA CD
      THE EFFECT OF THE 21-AMINOSTEROID U74006F ON THE CLINICAL COURSE OF ACUTE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

      Journal of the neurological sciences
    27. DIJKSTRA CD; VANDERVOORT ER; DEGROOT CJA; HUITINGA I; UITDEHAAG BMJ; POLMAN CH; BERKENBOSCH F
      THERAPEUTIC EFFECT OF THE D-2-DOPAMINE AGONIST BROMOCRIPTINE ON ACUTEAND RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

      Psychoneuroendocrinology
    28. POLMAN CH; BERTELSMANN FW; DEWAAL R; VANDIEMEN HAM; UITDEHAAG BMJ; VANLOENEN AC; KOETSIER JC
      4-AMINOPYRIDINE IS SUPERIOR TO 3,4-DIAMINOPYRIDINE IN THE TREATMENT OF PATIENTS WITH MULTIPLE-SCLEROSIS

      Archives of neurology
    29. UITDEHAAG BMJ; POLMAN CH; DEGROOT CJA; DIJKSTRA CD
      EFFECT OF K+ CHANNEL BLOCKERS ON THE CLINICAL COURSE AND HISTOLOGICALFEATURES OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

      Acta neurologica Scandinavica
    30. UITDEHAAG BMJ; DEGROOT CJA; KREIKE A; VANDERMEIDE PH; POLMAN CH; DIJKSTRA CD
      THE SIGNIFICANCE OF IN-SITU IA-ANTIGEN EXPRESSION IN THE PATHOGENESISOF AUTOIMMUNE CENTRAL-NERVOUS-SYSTEM DISEASE

      Journal of autoimmunity


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 17:44:14